De-identified EHR data from 30+ health systems — clinical notes, labs, imaging, and outcomes
Prescription, medical claims, and longitudinal patient data with provider-level analytics
Oncology-specific EHR-derived data with curated clinical endpoints and biomarker data
AI-curated oncology and specialty RWD with trial-matching and outcomes analytics
Healthcare Map with 330M+ patient journeys — claims, Rx, and provider activity
Privacy-preserving data linkage across claims, EHR, labs, and consumer datasets
Formulary coverage, payer policy, and market access intelligence across US health plans
Competitive pipeline intelligence, clinical trial analytics, and regulatory tracking
Biomedical literature search — 36M+ citations, abstracts, and full-text links via NCBI
Registry of 500K+ clinical studies with status, endpoints, and results data
Internal medical engagement tracking — MSL interactions, KOL touchpoints, congress activity
Pfizer publication pipeline — manuscripts, abstracts, posters by brand and indication
Where are the biggest evidence gaps for our oncology portfolio, and how does our publication output compare to competitors in those areas?
What does the patient journey look like for patients starting our recently launched therapy — where are they dropping off, and what access barriers exist?
Are we ready for the upcoming launch? Show me the status of our publication milestones, KOL engagement, formulary positioning, and competitive landscape.
Map evidence gaps by brand, indication, and subpopulation — surface where published data is thin and medical engagement is needed
Track competitor pipeline activity, label changes, publication trends, and congress presence to inform MA positioning
Map patient pathways from diagnosis through treatment — identify gaps in access, care transitions, and drop-off points
Measure Pfizer's share of publications, congress presentations, and KOL communications vs. competitors by therapeutic area
Pre-launch scorecard tracking publication milestones, messaging readiness, formulary access, and KOL engagement strategy
Strategy engine for designing post-market studies, registries, and RWE programs by population, geography, and indication
Select data sources and enter a question to begin
Select data sources, choose analytics modules, and enter your medical affairs question. The right visualization will emerge from your question.
